News
The gastrointestinal tract holds a vast community of diverse microbes, and many of them play crucial roles in our health. | ...
A phase 1 trial evaluating SENTI-202 demonstrated positive preliminary results in treating relapsed/refractory acute myeloid ...
However, AML can affect anyone at any age with around 100 children under the age of 19 also diagnosed each year. AML also has ...
A Phase I trial involving ten patients with relapsed or refractory classical Hodgkin lymphoma or T-cell lymphoma has achieved ...
In March 2022, Nick De Graw was a sophomore majoring in mechanical engineering at University of California, Irvine when he thought he might have mononucleosis. For a few weeks prior to visiting a ...
Scientists have developed a new, ready-made way to fight acute myeloid leukemia and other blood cancers that looks promising.
T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety ...
Breeze Hunter, 22, a student at Texas A&M University has revealed how a headache and pressure in her nose led her to discover ...
T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety profile in patients with two types of advanced thyroid cancer, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results